| [1] |
Bargman JM, Fredette N, Claire A. Characteristics and outcomes of fungal peritonitis in a modern north American cohort [J]. Perit Dial Int, 2015, 35(1): 78-84.
|
| [2] |
Chavada R, Kok J, Hal SV, et al. Seeking clarity within cloudy effluents: differentiating fungal from bacterial peritonitis in peritoneal dialysis patients [J]. PLoS One, 2011, 6(12): e28247.
|
| [3] |
Jayanthi GS, Kumar KV, Mallkarjuna HM. Fungal peritonitis in continuous ambulatory peritoneal dialysis: the impact of antifungal prophylaxis on patient and technique outcomes [J]. Indian J Nephrol, 2014, 24(5): 297-301.
|
| [4] |
Hu S, Tong R, Bo Y, et al. Fungal peritonitis in peritoneal dialysis: 5-year review from a North China center [J]. Infection, 2019, 47(1): 35-43.
|
| [5] |
Verma A, Mothu PN, Kalawat U, et al. Fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients [J]. J Clin Diagn Res, 2018, 12(8): 6-9.
|
| [6] |
Auricchio S, Giovenzana ME, Pozzi M, et al. Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation [J]. Clin Kidney J, 2018, 11(6): 874-880.
|
| [7] |
中国腹膜透析相关感染防治专家组. 腹膜透析相关感染的防治指南 [J]. 中华肾脏病杂志，2018, 34(2): 139-148.
|
| [8] |
Fan SL, Nicfhogartaigh C. Response to letter "Gram stain of peritoneal dialysis fluid: the potential of direct policy-determining importance in early diagnosis of fungal peritonitis" [J]. Perit Dial Int, 2019, 39(6): 575.
|
| [9] |
Chamroensakchai T, Manuprasert W, Puapatanakul P, et al. Serum galactomannan index for the rapid diagnosis of fungal peritonitis in patients with peritoneal dialysis [J]. Kidney Int Rep, 2019, 5(4): 530-534.
|
| [10] |
Giacobino J, Montelli AC, Barretti P, et al. Fungal peritonitis in patients undergoing peritoneal dialysis (PD) in Brazil: molecular identification, biofilm production and antifungal susceptibility of the agents [J]. J Med Vet Myco, 2016, 54(7): 725-732.
|
| [11] |
García AR, García MP. Aspectos clínicos y microbiológicos de la peritonitis fúngica en diálisis peritoneal [J]. Nefrología, 2009, 29(29): 506-517.
|
| [12] |
Szeto CC, Li PKT. Peritoneal dialysis-associated peritonitis [J]. Clin J Am Soc Nephrol, 2019, 14(7): 1100-1105.
|
| [13] |
Wong PN, Lo KY, Tong GMW, et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD [J]. Perit Dial Int, 2007, 27(5): 531-536.
|
| [14] |
Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial [J]. Perit Dial Int, 2010, 30(6): 619-625.
|
| [15] |
Lopes K, Rocha A, Rodrigues A, et al. Long-term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis [J]. Int J Artif Organs, 2013, 36(7): 484-488.
|
| [16] |
Prabhu MV, Subhramanyam SV, Gandhe S, et al. Prophylaxis against fungal peritonitis in CAPD-a single center experience with low-dose fluconazole [J]. Ren Fail, 2010, 32(7): 802-805.
|
| [17] |
Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment [J]. Perit Dial Int, 2016, 36(5): 481-508.
|
| [18] |
Wong P, Lo K, Tong G, et al. Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine, and delayed catheter replacement in continuous ambulatory peritoneal dialysis [J]. Perit Dial Int, 2008, 28(2): 155-162.
|
| [19] |
Pappas PG, Kauffman CA, Anders DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America [J]. Clin Infect Dis, 2016, 62: 1-50.
|
| [20] |
Ghebremedhin B, Bluemel A, Neumann KH, et al. Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole [J]. J Med Microbiol, 2009, 58(Pt 5): 678-682.
|
| [21] |
Prépost E, Tóth Z, Perlin DS, et al. Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis [J]. Infect Drug Resist, 2019, 12: 1805-1814.
|
| [22] |
Grimaldi D, Daugas E, Mougenot B, et al. Immuno-allergic interstitial nephritis related to fluindione: first biopsy proven cases [J]. Nephrol Dial Transplant, 2006, 21(1): 237.
|
| [23] |
Pasqualotto AC, Howard SJ, Moore CB, et al. Flucytosine therapeutic monitoring: 15 years experience from the UK [J]. J Antimicrob Chemother, 2007, 59(4): 791-793.
|
| [24] |
Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications [J]. Antimicrob Agents Chemother, 2009, 53(1): 24-34.
|
| [25] |
Liu YL, Huang CC, Kao MT. Residual renal function predicts outcome of fungal peritonitis in peritoneal dialysis patients [J]. Perit Dial Int, 2006, 26(3): 407-409.
|
| [26] |
Chang TI, Kim HW, Park JT, et al. Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center [J]. Perit Dial Int, 2011, 31(1): 60-66.
|